Background
==========

Asthma affects nearly 300 million people in the world, and its prevalence has been increasing in most developed countries \[[@b1-medscimonit-20-2617]\]. It is commonly thought that asthma is a multifactorial disease caused by complex interactions between a variety of genetic and environmental factors.

The Th2 cytokine interleukin-13 (IL-13), which shares significant pathways and many biological activities with IL-4, plays an important role in the development of asthma. It has been also demonstrated that expression of IL-13 is high in bronchial asthma lesions \[[@b2-medscimonit-20-2617]\]. Blease et al. demonstrated that ablating IL-13 production via delivery of a human IL-13 coupled to a derivative of *Pseudomonas* exotoxin to kill IL-13 producing cells *in vivo* inhibited all features of *Aspergillus*-induced airway disease \[[@b3-medscimonit-20-2617]\]. Walter et al. demonstrated that allergen challenge of IL-13-deficient mice failed to develop allergen-induced AHR, despite the presence of vigorous, Th2-biased, eosinophilic inflammation \[[@b4-medscimonit-20-2617]\].

Recently, the association between the *IL13* polymorphisms and susceptibility of pediatric asthma has been investigated extensively \[[@b5-medscimonit-20-2617]--[@b18-medscimonit-20-2617]\], but the results are conflicting and inconclusive. A previous meta-analysis suggested that *IL13--*1112C/T and +2044A/G polymorphisms were risk factors for asthma \[[@b19-medscimonit-20-2617]\], but it did not assess the association between the *IL13* polymorphisms and risk of pediatric asthma. Therefore, we performed this meta-analysis to precisely estimate the association between the *IL13--*1112C/T and +2044A/G polymorphisms and susceptibility to pediatric asthma.

Material and Methods
====================

Publication search
------------------

Online electronic databases (PubMed and EMBASE) were searched using the search terms: (interleukin-13 or IL-13) and (polymorphism or variant or variation) and (asthma or asthmatic). The last search was performed on 10 June 2014. We also searched the reference lists of all retrieved articles and relevant reviews. There was no language restriction.

Inclusion and exclusion criteria
--------------------------------

The following inclusion criteria were used: (1) the study must have evaluated the association between the *IL13* polymorphisms and pediatric asthma risk (age \<18 years); (2) the study must have a case-control design; and (3) sufficient data should have been provided to calculate odds ratios (OR) and 95% confidence interval (CI). Studies were excluded if any of the following conditions applied: (1) only abstracts or reviews were available, without sufficient data; (2) animal studies; and (3) studies were repeated or publications overlapped.

Data extraction and qualitative assessment
------------------------------------------

The following data were recorded from each article: first author, year of publication, ethnicity of participants, atopic status, numbers of cases and controls, and genotype number in cases and controls. The data were extracted by 2 of the authors independently (Liu and Li). Any discrepancy was resolved by discussion (Liu and Li).

Two authors (Liu and Li) completed the quality assessment independently. The Newcastle-Ottawa Scale (NOS) was used to evaluate the methodological quality, which scored studies by the selection of the study groups, the comparability of the groups, and the ascertainment of the outcome of interest. We considered a study awarded 0--3, 4--6, or 7--9 as a low-, moderate-, or high-quality study, respectively. Discrepancies were resolved by consensus and discussion (Liu and Li).

Statistical analysis
--------------------

The strength of association between the *IL13* polymorphisms and pediatric asthma risk was assessed by calculating OR with 95% CI. The pooled ORs were performed for the dominant model since most of the studies reported the results in this genetic model. Departure from Hardy-Weinberg equilibrium (HWE) in controls was tested by the chi-square test. A statistical test for heterogeneity was performed based on the Q statistic. The *P*\>0.10 of the Q test indicated a lack of heterogeneity among studies. If heterogeneity was observed among the studies, the random-effects model was used to estimate the pooled OR (the DerSimonian and Laird method). Otherwise, the fixed-effects model was adopted (the Mantel-Haenszel method). Stratified analysis was performed by ethnicity and atopic status, if possible. Potential publication bias was examined by Egger's test \[[@b20-medscimonit-20-2617]\]. All statistical tests were performed with the software STATA version 11.0 (Stata Corporation, College station, TX, USA). A *P* value \<0.05 was considered statistically significant.

Results
=======

Study characteristics
---------------------

[Figure 1](#f1-medscimonit-20-2617){ref-type="fig"} outlines the study selection process. Briefly, a total of 276 articles were identified after an initial search. After removing duplications, 55 articles were excluded. After reading the titles and abstracts, 197 articles were excluded because of abstracts, reviews, and irrelevant to pediatric asthma risk or *IL-13* polymorphisms. After reading full texts of the remaining 24 articles, 10 studies were then excluded and 14 studies remained \[[@b5-medscimonit-20-2617]--[@b18-medscimonit-20-2617]\]. One study reported 2 cohorts \[[@b16-medscimonit-20-2617]\], and each cohort was considered as a case-control study. Finally, 4710 asthma cases and 6086 controls were included in this meta-analysis. Ten case-control studies included Asian populations, 3 studies were performed in white populations, and study included African-Americans. All studies were assessed by NOS. The quality scores ranged from 6 to 9, suggesting that the methodological quality was acceptable. All studies suggested that the distribution of genotypes in the controls was consistent with HWE. The characteristics of each case-control study and the genotype in each study are presented in [Tables 1](#t1-medscimonit-20-2617){ref-type="table"} and [2](#t2-medscimonit-20-2617){ref-type="table"}.

Results of meta-analysis
------------------------

### IL13--1112C/T polymorphism and pediatric asthma risk

The association between *IL13--*1112C/T polymorphism and pediatric asthma risk was investigated in 9 case-control studies, with a total of 2944 cases and 2754 controls. The TT and CT genotypes of *IL13*-1112C/T polymorphism was associated with a significantly increased risk of pediatric asthma when compared with CC genotype (OR=1.14, 95% CI 1.01--1.28, *P*=0.04, *I2*=0%; [Figure 2](#f2-medscimonit-20-2617){ref-type="fig"}). When stratified by ethnicity, a significantly elevated risk was observed in whites (OR=1.29, 95% CI 1.02--1.63, *P*=0.03, *I^2^*=16%) but not in Asians (OR=1.09, 95% CI 0.94--1.26, *P*=0.24, *I^2^*=0%). Subgroup analysis of the atopic status showed that no increased risk was found in atopic patients (OR=1.18, 95% CI 0.94--1.47, *P=*0.15, *I^2^*=40%). Results of meta-analysis are listed in [Table 3](#t3-medscimonit-20-2617){ref-type="table"}. Publication bias was assessed by funnel plot. The shape of the funnel plot was symmetric ([Figure 3](#f3-medscimonit-20-2617){ref-type="fig"}). No significant publication bias was detected by Egger's test (*P*=0.54).

### IL13 +2044A/G polymorphism and pediatric asthma risk

The association between *IL13* +2044A/G polymorphism and pediatric asthma risk was investigated in 13 case-control studies, with a total of 4439 cases and 5089 controls. The AA and AG genotypes of *IL13* +2044A/G polymorphism was associated with a significantly increased risk of pediatric asthma when compared with GG genotype (OR=1.20, 95% CI 1.09--1.32, *P*\<0.01, *I^2^*=0%; [Figure 4](#f4-medscimonit-20-2617){ref-type="fig"}). When stratified by ethnicity, a significantly elevated risk was observed in Asians (OR=1.21, 95% CI 1.10--1.34, *P*\<0.01, *I^2^*=24%) but not in whites (OR=1.24, 95% CI 0.94--1.64, *P*=0.13, *I^2^*=0%). Subgroup analysis of the atopic status showed that no increased risk was found in atopic patients (OR=1.05, 95% CI 0.87--1.27, *P=*0.62, *I^2^*=0%). Results of meta-analysis are listed in [Table 3](#t3-medscimonit-20-2617){ref-type="table"}. Publication bias was assessed by funnel plot. The shape of the funnel plot was symmetric ([Figure 5](#f5-medscimonit-20-2617){ref-type="fig"}). No significant publication bias was detected by Egger's test (*P*=0.81).

Discussion
==========

We believe this is the first meta-analysis to investigate the association between *IL13--*1112C/T and +2044A/G polymorphisms and susceptibility to pediatric asthma. We found that *IL13--*1112C/T and +2044A/G polymorphisms were risk factors for developing asthma in children. In the subgroup analysis by ethnicity, we noted that whites carrying the --1112TT or CT genotypes had an increased pediatric asthma risk, and Asians carrying the +2044AA or AG genotypes had an increased pediatric asthma risk. This result suggests a possible association between environmental exposures and different genetic backgrounds. The subgroup analysis based on atopic status showed that *IL13--*1112C/T and +2044A/G polymorphisms were not associated with allergic asthma risk in children. However, only a few studies provided data on atopic status. Therefore, the positive association between these polymorphisms and allergic asthma risk in children could not be excluded. Liu et al. found that +2044A/G polymorphism of the IL-13 gene might play an important role in total serum IgE production \[[@b21-medscimonit-20-2617]\]. Thus, more studies with atopic subjects are needed.

IL-13 is produced by CD4^+^ T cells, NK T cells, mast cells, basophils, eosinophils, and nuocytes. IL-13 is thought to be a central regulator in IgE synthesis, mucus hypersecretion, airway hyperresponsiveness (AHR), and fibrosis \[[@b22-medscimonit-20-2617]\]. Polymorphisms in the IL-13 gene associated with asthma are described at --1112C/T and +2044A/G. It has been reported that the *IL13* +2044A/G polymorphism resulted in decreased affinity of IL-13 for IL-13Rα2, increased expression of IL-13, and phosphorylation of STAT6 \[[@b23-medscimonit-20-2617]\]. Functional analysis of the -1112C/T polymorphism identified a Yin-Yang 1 binding site activator that overlapped with a STAT motif repressor. The Yin-Yang 1 binding site was hypothesized to increase IL-13 transcription as opposed to STAT6-mediated repression of IL-13 transcription in Th2 cells \[[@b24-medscimonit-20-2617]\].

Heterogeneity is a potential problem that may affect the interpretation of the results. However, no significant heterogeneity existed in this meta-analysis. In addition, funnel plots and Egger's tests did not find potential publication bias. Altogether, these results suggest that the results of this meta-analysis are reliable.

Some limitations should be addressed. First, there was only 1 case-control study that investigated the association of IL-13 polymorphisms with pediatric asthma risk in African-Americans. Therefore, more studies with larger sample sizes are needed to investigate the association among African-Americans. Second, because small studies with negative results are less likely to published, the possibility of publication bias cannot be completely ruled out, even though the Egger's test and funnel plots did not show evidence of publication bias in this meta-analysis. Third, a lack of original data from the eligible studies limited evaluation of the effects of the gene-gene and gene-environment interactions during pediatric asthma development \[[@b25-medscimonit-20-2617]--[@b28-medscimonit-20-2617]\].

Conclusions
===========

The results if this meta-analysis suggest that *IL13--*1112C/T and +2044A/G polymorphisms are associated with increased pediatric asthma risk. Further studies with large sample sizes were needed to confirm our findings.
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###### 

Characteristics of the studies.

  Study      Year   Ethnicity          Atopic status                                               Case number   Control number   Quality score
  ---------- ------ ------------------ ----------------------------------------------------------- ------------- ---------------- ---------------
  Leung      2001   Asian              Mixed[\*](#tfn1-medscimonit-20-2617){ref-type="table-fn"}   157           54               6
  Xi         2004   Asian              NA                                                          43            31               6
  Kabesch    2006   Caucasian          NA                                                          73            773              7
  Kang       2007   Asian              NA                                                          374           242              8
  Chan       2008   Asian              Mixed                                                       273           141              8
  Kim        2008   Asian              Mixed[\*](#tfn1-medscimonit-20-2617){ref-type="table-fn"}   715           240              7
  Hua        2009   Asian              NA                                                          192           192              6
  Wang       2009   Asian              Mixed                                                       446           511              8
  Undarmaa   2010   Asian              Atopic                                                      325           336              9
  Wu         2010   Asian              NA                                                          252           227              6
  DeWan      2010   Mixed              Atopic                                                      104           503              7
  Baye 1     2011   Caucasian          NA                                                          413           298              8
  Baye 2     2011   African American   NA                                                          315           51               8
  Noguchi    2011   Asian              Mixed                                                       938           2376             9
  Munoz      2012   Caucasian          NA                                                          90            111              6

Both atopic and non-atopic data can be extracted.

NA -- not available.

###### 

Distribution of *IL13* genotype among patients and controls.

  Study          Patient   Control   HWE                                 
  -------------- --------- --------- -------- -------- -------- -------- -----
  Kabesch        34        33        6        471      263      39       Yes
  Kang           236       128       10       156      79       6        Yes
  Kim            455       236       25       155      80       6        Yes
  Hua            136       47        9        141      45       6        Yes
  Wang           316       113       17       357      136      18       Yes
  Undarmaa       186       119       20       227      98       11       Yes
  Baye 1         242       149       22       187      98       13       Yes
  Baye 2         116       152       49       18       25       8        Yes
  Munoz          45        34        11       58       46       7        Yes
  **+2044A/G**   **AA**    **AG**    **GG**   **AA**   **AG**   **GG**   
  Leung          29        74        54       7        26       21       Yes
  Xi             8         25        10       2        13       16       Yes
  Kang           48        166       160      28       100      101      Yes
  Chan           43        136       94       17       70       54       Yes
  Kim            90        318       301      28       100      99       Yes
  Wang           203       194       49       212      234      59       Yes
  Undarmaa       36        144       145      34       149      156      Yes
  Wu             36        111       105      18       84       125      Yes
  DeWan          5         34        65       23       171      309      Yes
  Baye 1         26        157       230      14       101      183      Yes
  Baye 2         8         87        220      1        14       36       Yes
  Noguchi        113       438       387      232      1033     1111     Yes
  Munoz          21        52        17       23       65       23       Yes

HWE -- Hardy-Weinberg equilibrium.

###### 

Detailed results of meta-analysis.

                 Association         Heterogeneity          
  -------------- ------------------- --------------- ------ ------
  **−1112C/T**                                              
  Overall        1.14 (1.01--1.28)   0.04            0.53   0.0
  Caucasian      1.29 (1.02--1.63)   0.03            0.31   16.0
  Asian          1.09 (0.94--1.26)   0.24            0.56   0.0
  Atopic         1.18 (0.94--1.47)   0.15            0.20   40.0
  **+2044A/G**                                              
  Overall        1.20 (1.09--1.32)   \<0.01          0.44   0.0
  Caucasian      1.24 (0.94--1.64)   0.13            0.76   0.0
  Asian          1.21 (1.10--1.34)   \<0.01          0.23   24.0
  Atopic         1.05 (0.87--1.27)   0.62            0.64   0.0
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